SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results
BOSTON and ROLLE, Switzerland, March 05, 2024 (GLOBE NEWSWIRE) — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a […]
Carbon Revolution To Present At The Emerging Growth Conference On Wednesday, March 6, 2024
GEELONG, Australia, March 05, 2024 (GLOBE NEWSWIRE) — Carbon Revolution plc (Nasdaq: CREV) (the “Company”), a Tier 1 OEM supplier […]
NxuOne™ Makes History as the First Reported Third-Party Charging System to Harness Tesla Cybertruck’s 800V Architecture
MESA, Ariz., March 05, 2024 (GLOBE NEWSWIRE) — Nxu, Inc. (NASDAQ: NXU) (“Nxu”, “the company”), a domestic technology company specializing […]
Vivid Seats Reports Fourth Quarter Results and Authorizes New Share Repurchase Program
CHICAGO, March 05, 2024 (GLOBE NEWSWIRE) — Vivid Seats Inc. (NASDAQ: SEAT) (“Vivid Seats” or “we”), a leading marketplace that […]
Matrix Service Company Receives Award From Long-Standing Client for Multiple Storage Tanks on the West Coast
TULSA, Okla., March 05, 2024 (GLOBE NEWSWIRE) — Matrix Service Company (Nasdaq: MTRX) announced today its subsidiary, Matrix North American Construction […]
Apogee Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
Positive interim results from APG777 Phase 1 healthy volunteer clinical trial exceeded objectives with approximately 75-day half-life which supports the […]
MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., March 05, 2024 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), a company focused on […]
Hooker Furnishings Declares Quarterly Dividend
MARTINSVILLE, Va., March 05, 2024 (GLOBE NEWSWIRE) — Hooker Furnishings Corporation (Nasdaq-GS: HOFT) announced that on March 4, 2024, its […]
RadNet, Inc. to Present at the 44th Annual Cowen & Company Healthcare Conference on Wednesday, March 6th
LOS ANGELES, March 05, 2024 (GLOBE NEWSWIRE) — RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic […]
Apogee Announces Positive Interim Results from Phase 1 Healthy Volunteer Trial for APG777, its Novel Half-Life Extended Anti-IL-13 Antibody for the Treatment for Atopic Dermatitis and Other Inflammatory Diseases, Exceeding its Trial Objectives Ahead of Schedule with Half-Life of Approximately 75 Days
Pharmacokinetic data support potential best-in-class profile with potential for improved clinical responses from greater exposures in induction than currently available […]
